GLOBAL HARMONIZATION TASK FORCE (GHTF) --------- UPDATE: PLANNING THE 2012 ACTIVITIES Laurent Sellès DHoU SANCO B2 “Cosmetics and Medical Devices” CAMD.

Slides:



Advertisements
Similar presentations
EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
Advertisements

GMDN Global Medical Device Nomenclature
Medical Devices Regulation in the European Union Albuquerque - 10 April 2012 Emmanuel Grimaud Perfea Innovation Lyon, France – Albuquerque, NM
The European Association Medical devices
Development of ISO standards for AD syringes SIGN Meeting Cambodia, October 2002 Injection technologies G Gerald Verollet.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
UDI and the GMDN (Global Medical Device Nomenclature)
EU Vigilance New Manufacturer Incident Report Form Piloting arrangements.
CE2012 Medical Device Regulatory Revision Austin Court, Birmingham 20th September 2012 Sponsored by.
. Summary of the consultation on the CES Census Recommendations Conference of European Statisticians 17 June 2015.
Revision of ISSAI 30 INTOSAI Code of Ethics
Revision of the Medical Device Directives The case of ‘Borderline’ Products used in a self-care context 48th AESGP Annual Meeting Nice, 6-8 June 2012 Laurent.
Slots/Windows of Opportunities HTA – Medical Devices Dr. Wolfgang Ecker EUnetHTA, Rome,
EDMA Page 1 EDMA Strategic Plan November 2002 John Place.
1 Security-related internal market measures on explosives FEEM AGM, Brussels, 5 June 2013 Julian Foley Desk Officer – Civil explosives and pyrotechnic.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
© EAAR 2012 Version 1, revised on Annual Report 2011.
GLOBAL HARMONIZATION TASK FORCE (GHTF) UPDATE: PLANNING THE 2012 ACTIVITIES Laurent Sellès DHoU SANCO B2 “Cosmetics and Medical Devices” CAMD.
The concept for a network of national Reference Laboratories for high risk IVDs – Results of the working group meeting 1.
Report on WG Clinical Investigation and Evaluation (CIE) Wolfgang Ecker Fed. Min. of Health, Austria Chairman CIE Cracow,
3rd ASAS TN Workshop 19 April – 21 April rd ASAS TN Workshop Session 4: Strategy and Implementation Package I Requirements Focus Group (“Rapid.
28th Meeting of the Competent Authorities Matthias Neumann Federal Ministry of Health, Germany Cracow, 27th of October 2011 Central Management Committee:
Report from COEN CAMD Krakow 27 – 28 October 2011 Lars Johansson.
Session 5 – CA work program, results and ongoing work – Report from NBOG Rainer Edelhäuser Zentralstelle der Länder für Gesundheitsschutz bei.
Proposal for a Regulation of the European Parliament and of the Council on medical devices and amending Directive 2001/83/EC, Regulation (EC) No 178/2002.
REVISION of IVD DIRECTIVE Regulation instead of Directive.
Summary of 4 th Informal Group on WLTP 14 January 2010 Palais des Nations, Geneva Informal document No. GRPE (59th GRPE, January 2010, agenda.
IMDRF VII National Competent Authority Report Exchange Programme Jean-François ROCHE DG GROWTH - Health Technology and Cosmetics Unit, European Commission.
Report from COEN CAMD Krakow 27 – 28 October 2011 Lars Johansson.
The use and administration of ICSMS in Sweden UNECE MARS meeting in Bratislava, 12 September 2012 Amina Makboul.
Resource-sharing amongst Member States in the field of vigilance and market surveillance 28th Meeting of the Competent Authorities for Medical Devices.
VICH General Principles and current update of VICH Outreach Forum activity 1.
-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.
Establishment of Medical Device GMP Requirements Hsiau-Wen Huang, Ph. D. Senior Researcher Bureau of Pharmaceutical Affairs Department of Health.
European Diagnostic Manufacturers Association EQA contribution and industry expectations Dr. Claude GIROUD – Chairman Standardization, Quality & Risk Management.
Slide 1 The contribution of a world-class regulatory environment to the future of the industry in Ireland Pat O’Mahony Chief Executive, Irish Medicines.
Activity Report and Future Planning. European thematic work 2006 Main priorities: 1.Gather and analyze "good practice" and general information on operations.
Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.
Exchange of Letter on Medical Device -The Experience of Chinese Taipei Hsiau-Wen Huang, Ph. D. Senior Researcher Bureau of Pharmaceutical Affairs Department.
Health and Consumers Health and Consumers Introduction to the new Medical Device Regulations and their impact on medical software DG for Internal Market,
Director, Regulatory Affairs
Clusters working group COM/CAMD New Regulations
Update on EU regulatory developments
Industry Implementation Priorities & Challenges COM/CAMD Stakeholders meeting on the new MD and IVD Regulations 9 March, 2017 John Brennan Director.
Flowchart on overview of requirements
The European Association Medical devices
66 items – 70% of circulated products
Irena Prat and Josée Hansen World Health Organization
Director, Asia Pacific Japan and U.S. Clinical Operations
Nicole Denjoy COCIR Secretary General
Michelle Limoli, Pharm.D.
11th GHTF CONFERENCE WASHINGTON DC OCTOBER 2007 SG5: CLINICAL EVALUATION STATUS REPORT SUSANNE LUDGATE Name MHRA Date 2007.
International Medical Device Regulatory Harmonization
Simplification of the UN Lighting and Light-signalling Regulations
“Association Presentation
Quality and Regulatory Planning – the way forward?
EA/CC Report Kevin Belson
Medical Device Design and Development
Larry Kessler, Sc.D. Director
Task Force – Cyber Security, Data Protection and Over-the-Air issues
The European Association Medical devices
The European Association Medical devices
Steering Committee, Eurostat, Luxembourg, 4 February 2011
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Towards International Harmonized Nomenclature for Medical Devices
Strategic Coordination Group 2007 Reporting Guidance on Monitoring
Item 4.2 – Towards the 2016 AES Philippe Lombardo Eurostat-F5
Draft CIS work programme
EUnetHTA Assembly May 2018.
Joint Action on Market Surveillance of medical devices (JAMS)
Presentation transcript:

GLOBAL HARMONIZATION TASK FORCE (GHTF) UPDATE: PLANNING THE 2012 ACTIVITIES Laurent Sellès DHoU SANCO B2 “Cosmetics and Medical Devices” CAMD Competent Authorities’ Meeting on Medical Devices

Global Harmonisation Task Force - Conceived in 1992, rotation of Chairmanship every 3 years - Purpose: international harmonization in MD regulations for safety, effectiveness, performance adequacy/quality of MDs - Publication of harmonized guidance docs on regulatory practices. - Guidance docs for adoption by Regulatory Authorities. - GHTF cooperates with Asian Harmonisation Working Party AHWP

May 2011 Europe’s participation in GHTF Steering Committee Laurent Sellès (COM) - Matthias Neumann (DE) Joanna Kilkowska (PL) – Jean-Claude Ghislain (FR) Benny Ons (EDMA) - François Simondet (EUROM VI) Jean-Yves Carentz (Eucomed) – Nicole Denjoy (COCIR) SG1 Premarket evaluation Chair [N. Shadeed (CAN)] P. Bischoff-Everding (COM) Alan Green (EUROM VI) Peter Linders (COCIR) _______________ SG1 Subgroup IVD Marie-Lise Migueres (FR) C é line Bourguignon (COM) Benny Ons (EDMA) Michael Thein (EDMA) Petra Kaars Wiele (EDMA) SG2 Post market surveillance /vigilance Chair Isabelle Demade (COM) Carmen Ruiz-Vilar (ES) Ekkehard St ö sslein (DE) Philippe Auclair (Eucomed) Bertram König (Eurom VI) SG3 Quality system Chair Egan Cobbold (CAN) Rainer Edelh ä user (DE) Carlos Arglebe (Cocir) Emmett Evereux (Eucomed) SG4 Auditing Chair Jan Welch (USA) Maintenance mode Peter Studer (CH) Philippe Lartigue (Cocir) Bertram Koenig (EuromVI) Fran ç ois Simondet ( EuromVI) Stefan Preiss (EU NB) John Worroll (EU NB) SG5 Clinical safety & Performance Chair S. Ludgate (UK) Wolfgang Ecker (AT) Isabel Scuntaro (CH) Benny Ons (EDMA) Christian Bailleul (Eucomed) Peter Rattke (COCIR) AHWG GMDN (Chair Rohan Hammett AUS) Susanne H ö ke (COM) AHWG “ UDI ” Chair: Laurent Sell è s (COM) Matthias Neumann (DE) Jesus Rueda (EDMA) Volker Zeinar(Eucomed) AHWG “ IAF ” (International Accreditation Forum) Chair: Roland Rotter/Egan Cobbold (CAN)

European coordination Information of progress of reflection: -MDEG (June, November 2010) and CA meetings (March, September 2010, February 2011) -Regular preparatory meetings prior to GHTF Steering Committee sessions (MS, Industry invited) In the Steering Committee, MS represented - by DE, NL, IT (in ) - by DE, IT, PL (in ) - by DE, PL, FR (in 2011)

STEERING COMMITTEE MEETING May 2011 BRISBANE At the Steering Committee (SC) meeting in Brisbane: - Japan (SC Chair) decided to : - cancel the SC meeting planned in October maintain the two SC meetings April and October will be for ‘closing the books’. -A conference could be part of an SC meeting and acknowledge the achievements of GHTF.

SG1 work programme  Out for public comments (until 5 Feb. 2012): Principles of Conformity Assessment for Medical Devices (SG1(PD)/N078R03); Principles of Medical Devices Classification (SG1(PD)/N077R04)  Finalization of the revision of: Definition of the Term "Medical Device“; Essential Principles of Safety and Performance of Medical Devices  Cooperation of IVD subgroup with SG5: 3 guidance documents related to clinical evidence (see next slide) Prior to GHTF closure…

IVD subgroup / SG 5  Out for public comments (until 21 March 2012): Clinical Evidence for IVD Medical Devices - Key Definitions and Concepts (SG5(PD)/N6R3); Clinical Evidence for IVD Medical Devices - Scientific Validity Determination and Performance Evaluation (SG5(PD)/N7R4)  Finalization of working draft: Clinical performances studies for In Vitro Diagnostic Medical Devices Prior to GHTF closure…

SG2 work programme  Finalize N111 on the def. & classification of FSCA.  Finalize N87 on the electronic transfer of AE data between MFRs, Authorised Reps and NCAs.  Publication of info on the SG2 NCARs Exchange Programme (incl. NCARs stats) on GHTF website. Prior to GHTF closure…

SG2-SG5 joint action Completion of the proposed guidance on AE reporting during pre-market clinical investigation. Also in 2012…